1 results match your criteria: "Center Tower Ste. 4100[Affiliation]"
Pharmacotherapy Options in the Management of Raynaud's Phenomenon.
Curr Treatm Opt Rheumatol
September 2018
Division of Rheumatology, Johns Hopkins University, 5200 Eastern Avenue, MFL Building, Center Tower Ste. 4100, Baltimore, MD, 21224.
Purpose Of Review: Multiple classes of medications have been studied for the treatment of Raynaud's phenomenon (RP) with or without digital ischemia. The goal of this review is to discuss the outcomes of recent studies and to report on our approach to the management of RP in light of the available evidence.
Recent Findings: Comparing treatments for RP remains a challenge as efficacy endpoint vary widely among trials.